首页> 美国卫生研究院文献>BioMed Research International >Significance of “Not Detected but Amplified” Results by Real-Time PCR Method for HPV DNA Detection
【2h】

Significance of “Not Detected but Amplified” Results by Real-Time PCR Method for HPV DNA Detection

机译:实时PCR法“未检出但扩增”结果对HPV DNA检测的意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human papillomavirus (HPV) infection is an important etiologic factor in cervical carcinogenesis. Various HPV DNA detection methods have been evaluated for clinicopathological level. For the specimens with normal cytological finding, discrepancies among the detection methods were frequently found and adequate interpretation can be difficult. 6,322 clinical specimens were submitted and evaluated for real-time PCR and Hybrid Capture 2 (HC2). 573 positive or “Not Detected but Amplified” (NDBA) specimens by real-time PCR were additionally tested using genetic analyzer. For the reliability of real-time PCR, 325 retests were performed. Optimal cut-off cycle threshold (C T) value was evaluated also. 78.7% of submitted specimens showed normal or nonspecific cytological finding. The distributions of HPV types by real-time PCR were not different between positive and NDBA cases. For positive cases by fragment analysis, concordance rates with real-time PCR and HC2 were 94.2% and 84.2%. In NDBA cases, fragment analysis and real-time PCR showed identical results in 77.0% and HC2 revealed 27.6% of concordance with fragment analysis. Optimal cut-off C T value was different for HPV types. NDBA results in real-time PCR should be regarded as equivocal, not negative. The adjustment of cut-off C T value for HPV types will be helpful for the appropriate result interpretation.
机译:人乳头瘤病毒(HPV)感染是宫颈癌发生的重要病因。已经针对临床病理学水平评估了各种HPV DNA检测方法。对于具有正常细胞学发现的标本,经常会发现检测方法之间的差异,并且难以充分解释。提交了6,322个临床标本,并进行了实时PCR和Hybrid Capture 2(HC2)评估。另外,使用基因分析仪对573个阳性或“未检出但未扩增”(NDBA)样品进行实时PCR检测。为了实时PCR的可靠性,进行了3​​25次重新测试。还评估了最佳截止周期阈值(C T)。 78.7%的标本标本显示正常或非特异性细胞学发现。实时PCR和NDBA病例中通过实时PCR得出的HPV类型分布没有差异。对于通过片段分析得到的阳性病例,实时荧光定量PCR和HC2的符合率分别为94.2%和84.2%。在NDBA病例中,片段分析和实时PCR显示的结果相同,为77.0%,而HC2显示与片段分析的一致性为27.6%。对于HPV类型,最佳截止C T值有所不同。 NDBA在实时PCR中的结果应视为模棱两可,而不是阴性。调整HPV类型的临界C T值将有助于适当的结果解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号